The European Medicines Agency has started a review of medicines containing finasteride and dutasteride following concerns ...

The EMA anticipates that the ability to access scientific advice will foster innovation among medical device manufacturers.

Moleculin Biotech (MBRX) has received first country regulatory approval in Europe to begin recruiting for its Phase 3 pivotal trial protocol ...

A new method has been created for determining N-nitrosamines (NAs) in pharmaceutical preparations using liquid chromatography with tandem mass spectrometry.

Librela (bedinvetmab injection) is a monthly injectable monoclonal antibody, for which real-world drug experience data has ...

Request To Download Free Sample of This Strategic Report @ Highlighted with 33 tables and 60 figures, this 119-page report Europe Pharmacovigilance and Drug Safety Software Market 2021-2031 by ...

PARSIPPANY, N.J. - Zoetis Inc . (NYSE: NYSE:ZTS), a global leader in animal health with a market capitalization of $77.57 billion, has announced an immediate update to the U.S. label for its canine ...

Zoetis Inc. today announced that it has updated the U.S. label for Librela® (bedinvetmab injection), following its submission ...

The European Medicines Agency (EMA) has recommended granting marketing authorization for the pneumococcal vaccine Capvaxive ...

This acquisition represents a key milestone in our growth journey, consolidating our pharmacovigilance leadership across the French and European market. It underscores our commitment to providing ...